ERF logo

Eurofins Scientific SE Stock Price

ENXTPA:ERF Community·€11.8b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 33 Fair Values set on narratives written by author

ERF Share Price Performance

€67.74
1.20 (1.80%)
€72.53
Fair Value
€67.74
1.20 (1.80%)
4.2% undervalued intrinsic discount
€70.74
Fair Value
Price €67.74
AnalystConsensusTarget €70.74
AnalystLowTarget €58.00
AnalystHighTarget €86.00

ERF Community Narratives

·
Fair Value €72.53 6.6% undervalued intrinsic discount

Digitalization And Automation Will Unlock Future Diagnostics Potential

0users have liked this narrative
0users have commented on this narrative
20users have followed this narrative
·
Fair Value €58 16.8% overvalued intrinsic discount

Automation And Regulatory Hurdles Will Erode Traditional Lab Margins

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
·
Fair Value €86 21.2% undervalued intrinsic discount

Digital Investments And Rising Safety Mandates Will Expand Advanced Diagnostics

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
€72.53
6.6% undervalued intrinsic discount
Revenue
6.37% p.a.
Profit Margin
10.06%
Future PE
16.09x
Price in 2029
€89.19
€58
16.8% overvalued intrinsic discount
Revenue
5.25% p.a.
Profit Margin
8.71%
Future PE
16.71x
Price in 2029
€71.49
€86
21.2% undervalued intrinsic discount
Revenue
8.67% p.a.
Profit Margin
10.31%
Future PE
18.96x
Price in 2029
€105.68

Trending Discussion

No trending discussion available.

Updated Narratives

ERF logo

ERF: Acquisition Plans And Buybacks Will Support Balanced Long Term Outlook

Fair Value: €72.53 6.6% undervalued intrinsic discount
20 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
ERF logo

ERF: Acquisition Plans And Hantavirus Testing Will Pressure Margins And Future P/E

Fair Value: €58 16.8% overvalued intrinsic discount
1 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
ERF logo

ERF: Expanded Hantavirus Testing Network Will Support Re Rating Potential

Fair Value: €86 21.2% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Undervalued with proven track record.

1 Risk
4 Rewards

Eurofins Scientific SE Key Details

€7.4b

Revenue

€5.7b

Cost of Revenue

€1.7b

Gross Profit

€1.2b

Other Expenses

€469.9m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
2.71
23.13%
6.36%
87.3%
View Full Analysis

About ERF

Founded
1987
Employees
65000
CEO
Gilles Martin
WebsiteView website
www.eurofins.com

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. It provides services, such as agroscience, including biological assessment, consumer and human, environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, including sustainability, audit, certification, quality inspection, QA-QC programme, and food and dietary supplement labelling services; biopharma, and clinical diagnostics. The company also offers consumer product testing, which include sustainability, testing, certifications and approvals, expert services and regulatory, inspections, audits, consumer research and sensory evaluation, and training courses; cosmetics and personal care; and electrical and electronics laboratories services. In addition, it provides environment testing, including maritime, water, air, soil, building material, pollution, waste, fuel/oil, microplastics, and radioactivity testing; and food and feed testing that include allergen, audit and certification, authenticity, carbohydrates, consulting, dioxins and POPs, food irradiation, GMO, heavy metal, melamine, microbiology, molecular biology, mycotoxin, nutritional analyses, organic contaminants, pesticide, veterinary drug, vitamin, and residual DNA testing. Further, the company provides forensic, genomic, maritime, materials and engineering, REACH, and sensory and consumer services, as well as in vitro diagnostics and PSS insourcing solutions. The company was founded in 1987 and is headquartered in Luxembourg, Luxembourg.

Recent ERF News & Updates

Narrative Update Jul 21

ERF: Acquisition Plans And Hantavirus Testing Will Pressure Margins And Future P/E

Analysts have increased their fair value estimate for Eurofins Scientific from €48.32 to €58.00, citing updated assumptions for revenue growth, profit margins and future P/E that support a higher long-term price target framework. What's in the News Eurofins Scientific agreed to acquire Element Materials Technology's Life Sciences Testing Services business in North America, with closing subject to customary conditions and regulatory approvals and targeted for Q4 2026, according to recent transaction announcements.

Recent updates

No updates